PAEME pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PAEME pharma
Largest movements
- Current investments +€100,000
new in 2025: €100,000
- Cash -€77,254
down €77,254 (-62.0%), from €124,583 to €47,330
mainly Current investments (-€100,000) and Tax, wage and social debts (-€5,812)
- Receivables within one year -€16,213
down €16,213 (-17.4%), from €93,044 to €76,831
of which Trade receivables: -€24,200
- Reserves +€9,150
up €9,150 (+1.8%), from €516,073 to €525,223
- Gross operating margin -€33,536
down €33,536 (-63.3%), from €53,014 to €19,477
- Taxes -€11,168
down €11,168 (-84.5%), from €13,213 to €2,045
- Financial charges -€1,136
down €1,136 (-14.6%), from €7,757 to €6,621
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €599,481 | €607,089 | +€7,608 | +1.3% |
| Fixed assets | 21/28 | €380,000 | €381,036 | +€1,036 | +0.3% |
| Tangible fixed assets | 22/27 | - | €1,036 | +€1,036 | |
| Plant, machinery and equipment | 23 | - | €1,036 | +€1,036 | |
| Financial fixed assets | 28 | €380,000 | €380,000 | = | 0.0% |
| Current assets | 29/58 | €219,481 | €226,052 | +€6,571 | +3.0% |
| Amounts receivable within one year | 40/41 | €93,044 | €76,831 | -€16,213 | -17.4% |
| Trade receivables | 40 | €24,200 | - | -€24,200 | |
| Other amounts receivable | 41 | €68,844 | €76,831 | +€7,987 | +11.6% |
| Current investments | 50/53 | - | €100,000 | +€100,000 | |
| Cash at bank and in hand | 54/58 | €124,583 | €47,330 | -€77,254 | -62.0% |
| Deferred charges and accrued income | 490/1 | €1,853 | €1,891 | +€38 | +2.1% |
| Total equity and liabilities | 10/49 | €599,481 | €607,089 | +€7,608 | +1.3% |
| Equity | 10/15 | €528,473 | €537,623 | +€9,150 | +1.7% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €516,073 | €525,223 | +€9,150 | +1.8% |
| Distributable reserves | 133 | €516,073 | €525,223 | +€9,150 | +1.8% |
| Amounts payable | 17/49 | €71,008 | €69,466 | -€1,542 | -2.2% |
| Amounts payable within one year | 42/48 | €62,100 | €63,726 | +€1,625 | +2.6% |
| Trade debts | 44 | €222 | €3,644 | +€3,421 | +1,538% |
| Suppliers | 440/4 | €222 | €3,644 | +€3,421 | +1,538% |
| Taxes, remuneration and social security | 45 | €8,477 | €2,665 | -€5,812 | -68.6% |
| Taxes | 450/3 | €8,477 | €2,665 | -€5,812 | -68.6% |
| Other amounts payable | 47/48 | €53,401 | €57,417 | +€4,016 | +7.5% |
| Accrued charges and deferred income | 492/3 | €8,907 | €5,740 | -€3,167 | -35.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €151 | €271 | +€120 | +79.4% |
| Other operating charges | 640/8 | €784 | €691 | -€93 | -11.8% |
| Non-recurring operating charges | 66A | - | €2,072 | +€2,072 | |
| Gross operating margin | 9900 | €53,014 | €19,477 | -€33,536 | -63.3% |
| Operating profit (loss) | 9901 | €52,078 | €16,442 | -€35,636 | -68.4% |
| Financial income | 75/76B | €1,826 | €1,373 | -€453 | -24.8% |
| Recurring financial income | 75 | €1,826 | €1,373 | -€453 | -24.8% |
| Financial charges | 65/66B | €7,757 | €6,621 | -€1,136 | -14.6% |
| Recurring financial charges | 65 | €7,757 | €6,621 | -€1,136 | -14.6% |
| Profit (loss) for the period before taxes | 9903 | €46,147 | €11,194 | -€34,952 | -75.7% |
| Income taxes | 67/77 | €13,213 | €2,045 | -€11,168 | -84.5% |
| Profit (loss) for the period | 9904 | €32,934 | €9,150 | -€23,784 | -72.2% |
| Profit (loss) for the period to be appropriated | 9905 | €32,934 | €9,150 | -€23,784 | -72.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.